At the request of Scandion Oncology, Scandion Oncology equity rights will be
traded on First North Growth Market as from July 19, 2024.
Security name: Scandion Oncology TO 2
--------------------------------------
Short name: SCOL TO 2
--------------------------------------
ISIN code: DK0062957031
--------------------------------------
Orderbook ID: 345977
--------------------------------------
Terms: One (1) warrant series TO 2 entitles the holder to subscribe for one (1)
new share in the Company to a subscription price corresponding to
seventy (70) per cent of the volume weighted average price of the
Company's share during the period from and including 16 October 2024 up
to and including 29 October 2024, however not lower than the shares'
nominal value and not higher than 125 per cent of the subscription
price in the Rights Issue. Subscription of shares by exercise of
warrants of series TO 2 will take place during the period from and
including 4 November 2024 up to and including 18 November 2024.
--------------------------------------------------------------------------------
1 option rights gives the right to subscribe for 1 new share in Scandion
Oncology
--------------------------------------------------------------------------------
Subscr November 4, 2024 - November 18, 2024
iption
perio
d:
--------------------------------------------------------------------------------
Last November 14, 2024
tradi
ng
day:
--------------------------------------------------------------------------------
This information is distributed at the request of the Certified Adviser, Västra
Hamnen Corporate Finance AB. For further information, please call Västra Hamnen
Corporate Finance AB on 040 200 250.© 2024 GlobeNewswire
